FAMOTIDINE
PEPTIC ULCER AGENTS · MULTIPLE ENDOCRINE NEOPLASIA ·+13
BEDFORD LABS
Drug class
Histamine-2 Receptor Antagonists (H2 Antagonists)
Histamine-2 receptor antagonists, commonly termed H2 antagonists or H2 blockers, are a recognized class of acid-suppressing pharmacotherapeutic agents. Read more about Histamine-2 Receptor Antagonists (H2 Antagonists)
159 drugs in this class 93 manufacturers
Drugs in Histamine-2 Receptor Antagonists (H2 Antagonists)
NIZATIDINE
PEPTIC ULCER AGENTS · REFLUX ESOPHAGITIS ·+7
DR.REDDY'S LAB
HEARTBURN RELIEF (magnesium carbonate/aluminum hydroxide)
ANTACIDS · DYSPEPSIA ·+1
CVS
FAMOTIDINE (famotidine in sodium chloride, iso-osmotic/PF)
PEPTIC ULCER AGENTS · MULTIPLE ENDOCRINE NEOPLASIA ·+13
Baxter Healthcare Company
ACID CONTROLLER COMPLETE (famotidine/calcium carbonate/magnesium hydroxide)
PEPTIC ULCER AGENTS · GASTROESOPHAGEAL REFLUX DISEASE ·+3
TARGET CORP
ACID CONTROLLER COMPLETE (famotidine/calcium carbonate/magnesium hydroxide)
PEPTIC ULCER AGENTS · GASTROESOPHAGEAL REFLUX DISEASE ·+3
TARGET CORP
HEARTBURN RELIEF (cimetidine)
PEPTIC ULCER AGENTS · DYSPEPSIA ·+1
TOPCO
FAMOTIDINE (famotidine/PF)
PEPTIC ULCER AGENTS · MULTIPLE ENDOCRINE NEOPLASIA ·+13
BEDFORD LABS
FAMOTIDINE
PEPTIC ULCER AGENTS · MULTIPLE ENDOCRINE NEOPLASIA ·+13
LUPIN PHARMACEU
Filter & compare in the drug finder →
Opens the drug finder with Histamine-2 Receptor Antagonists (H2 Antagonists) preselected. Add indication or manufacturer filters there.
Histamine-2 receptor antagonists, commonly termed H2 antagonists or H2 blockers, are a recognized class of acid-suppressing pharmacotherapeutic agents.
They function through competitive inhibition of histamine at the H2 receptors located on gastric parietal cells, thereby decreasing intracellular cyclic adenosine monophosphate production and markedly reducing basal and stimulated gastric acid secretion.
Clinically, members of this class are utilized to prevent and treat acid-peptic disorders, primarily gastroesophageal reflux disease, active duodenal and gastric ulcers, and pathological hypersecretory conditions such as Zollinger-Ellison syndrome.
In both prescription and over-the-counter forms, they also serve to alleviate acid indigestion and provide stress ulcer prophylaxis in hospitalized patients.
-
fda.gov
Histamine-2 receptor antagonists, commonly termed H2 antagonists or H2 blockers, are a recognized class of acid-suppressing pharmacotherapeutic agents In both prescription and over-the-counter forms, they also serve to alleviate acid indigestion and provide stress ulcer prophylaxis in hospitalized patients
-
nih.gov
Histamine-2 receptor antagonists, commonly termed H2 antagonists or H2 blockers, are a recognized class of acid-suppressing pharmacotherapeutic agents They function through competitive inhibition of histamine at the H2 receptors located on gastric parietal cells, thereby decreasing intracellular cyclic adenosine monophosphate production and markedly reducing basal and stimulated gastric acid secretion Clinically, members of this class are utilized to prevent and treat acid-peptic disorders, prim...
-
nih.gov
They function through competitive inhibition of histamine at the H2 receptors located on gastric parietal cells, thereby decreasing intracellular cyclic adenosine monophosphate production and markedly reducing basal and stimulated gastric acid secretion
-
nih.gov
They function through competitive inhibition of histamine at the H2 receptors located on gastric parietal cells, thereby decreasing intracellular cyclic adenosine monophosphate production and markedly reducing basal and stimulated gastric acid secretion
-
fda.gov
Clinically, members of this class are utilized to prevent and treat acid-peptic disorders, primarily gastroesophageal reflux disease, active duodenal and gastric ulcers, and pathological hypersecretory conditions such as Zollinger-Ellison syndrome
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.